Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark G Wing

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Toxicology Letters|June 8, 2002
In vitro preclinical lead optimisation technologies (PLOTs) in pharmaceutical developmentChristopher K Atterwill, Mark G Wing
Molecular Biotechnology|May 4, 2004
Preclinical safety testing of biotechnology-derived pharmaceuticals: understanding the issues and addressing the challengesFrank R Brennan, Leigh Shaw, Mark G Wing, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 10, 2006
A novel role for Sema3A in neuroprotection from injury mediated by activated microgliaHenry H Majed, Siddharthan Chandran, Simone P Niclou, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Toxicology Letters|June 8, 2002
In vitro preclinical lead optimisation technologies (PLOTs) in pharmaceutical developmentChristopher K Atterwill, Mark G Wing
Molecular Biotechnology|May 4, 2004
Preclinical safety testing of biotechnology-derived pharmaceuticals: understanding the issues and addressing the challengesFrank R Brennan, Leigh Shaw, Mark G Wing, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 10, 2006
A novel role for Sema3A in neuroprotection from injury mediated by activated microgliaHenry H Majed, Siddharthan Chandran, Simone P Niclou, et al.
Pageof 1